Breaking News Instant updates and real-time market news.

ABT

Abbott

$69.34

1.23 (1.81%)

08:31
10/15/18
10/15
08:31
10/15/18
08:31

Abbott names Robert Ford as President, COO

Abbott announced that Robert Ford has been named president and COO, effective immediately. Ford, a 22-year Abbott veteran, was most recently executive vice president of Medical Devices, Abbott's largest business. In addition to his current responsibilities for Medical Devices, Ford will assume responsibility for all of Abbott's operating businesses. Ford will continue to report to Miles D. White, chairman of the board and CEo of Abbott. Ford has held various management positions across several of Abbott's businesses, including Diagnostics, Nutrition and Medical Devices. As head of Abbott's Medical Devices business for the past three years, Ford oversaw the integration of the St. Jude Medical acquisition, the largest acquisition in Abbott's history. He previously led Abbott's Diabetes Care business and the launch of Abbott's revolutionary glucose monitoring system, FreeStyle Libre.

  • 17

    Oct

ABT Abbott
$69.34

1.23 (1.81%)

10/10/18
RBCM
10/10/18
NO CHANGE
Target $77
RBCM
Outperform
Abbott price target raised to $77 from $70 at RBC Capital
RBC Capital analyst Glenn Novarro raised his price target on Abbott to $77, saying that while the company is faced with "tougher comps" in Q3 relative to the 7.5% organic growth in the first half of 2018, some upside to consensus is a "distinct possibility". The analyst is particularly positive on the Medical Devices and Diagnostics segments potentially driving the upside thanks to the momentum of new products such as Libre and Alinity. Novarro keeps his Outperform rating on Abbott and also raises his FY19 EPS view to $3.30 from $3.27.
10/08/18
JPMS
10/08/18
NO CHANGE
Target $81
JPMS
Overweight
JPMorgan boosts Abbott target to $81, says buy into earnings
JPMorgan analyst Robbie Marcus raised his price target for Abbott Laboratories to $81 from $77 and recommends buying the shares into the Q3 earnings report. With the addition of the COAPT data for MitraClip in functional mitral regurgitation and the roadway ahead for Libre, Abbott has the ability to be a premium growth MedTech company for the near-to-midterm, Marcus tells investors in a research note. And in the near-term, the analyst sees upside to the company's Q3 earnings on both the top and bottom lines. He believes Abbott has the potential to trade at a premium versus peers and keeps an Overweight rating on the shares.
10/05/18
COWN
10/05/18
NO CHANGE
Target $86
COWN
Outperform
Abbott price target raised to $86 from $72 at Cowen
Cowen analyst Joshua Jennings raised his price target on Abbott to $86 from $72 and said it remains a top pick. The analyst cited increased visibility from Libre and MitraClip reinforcing confidence in top tier revenue and earnings growth, which he sees supporting a peer average multiple. Jennings reiterated his Outperform rating on Abbott shares.
10/02/18
PIPR
10/02/18
NO CHANGE
PIPR
Overweight
Abbott's Libre sensor prices 'creeping higher,' says Piper Jaffray
Piper Jaffray analyst JP McKim noted that his tracking of the weekly price of Abbott's (ABT) FreeStyle Libre Sensors indicates that prices have risen over the last four weeks by varying amounts depending on the area of the country, but "no matter what area, prices have gone up." He reads this as evidence that the "aggressive pharmacy discounting" Abbott did in the early launch days are coming to an end and reiterates his previously communicated belief that CGM demand has hit an inflection point and that the market has room for multiple players, including both Abbott and DexCom (DXCM). McKim keeps an Overweight rating on DexCom shares.

TODAY'S FREE FLY STORIES

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

05:58
10/17/19
10/17
05:58
10/17/19
05:58
General news
Boris Johnson announces 'great new' Brexit deal »

Prime Minister of the…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

05:55
10/17/19
10/17
05:55
10/17/19
05:55
General news
European Commission President says Brexit deal has been reached »

President of the European…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEGRY

Weir Group

$0.00

(0.00%)

05:51
10/17/19
10/17
05:51
10/17/19
05:51
Downgrade
Weir Group rating change  »

Weir Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHHF

Sophos Group

$0.00

(0.00%)

05:50
10/17/19
10/17
05:50
10/17/19
05:50
Downgrade
Sophos Group rating change  »

Sophos Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASOMY

Asos

$0.00

(0.00%)

05:49
10/17/19
10/17
05:49
10/17/19
05:49
Upgrade
Asos rating change  »

Asos upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

BC

Brunswick

$55.47

0.46 (0.84%)

05:48
10/17/19
10/17
05:48
10/17/19
05:48
Downgrade
Brunswick rating change  »

Brunswick downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BBT

BB&T

$53.00

0.25 (0.47%)

05:47
10/17/19
10/17
05:47
10/17/19
05:47
Earnings
BB&T reports Q3 adj. EPS $1.07, consensus $1.03 »

Reports Q3 revenue $3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 08

    Nov

ASML

ASML

$254.52

-13.04 (-4.87%)

05:45
10/17/19
10/17
05:45
10/17/19
05:45
Downgrade
ASML rating change  »

ASML downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PFBC

Preferred Bank

05:43
10/17/19
10/17
05:43
10/17/19
05:43
Downgrade
Preferred Bank rating change  »

Preferred Bank downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

SAM

Boston Beer

$382.92

-4.92 (-1.27%)

05:41
10/17/19
10/17
05:41
10/17/19
05:41
Upgrade
Boston Beer rating change  »

Boston Beer upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SBNY

Signature Bank

$118.68

-0.1 (-0.08%)

05:41
10/17/19
10/17
05:41
10/17/19
05:41
Earnings
Signature Bank reports Q3 EPS $2.75, consensus $2.70 »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 29

    Oct

NGG

National Grid

$57.08

0.305 (0.54%)

05:34
10/17/19
10/17
05:34
10/17/19
05:34
Upgrade
National Grid rating change  »

National Grid upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGVSF

Tryg

$0.00

(0.00%)

05:33
10/17/19
10/17
05:33
10/17/19
05:33
Upgrade
Tryg rating change  »

Tryg upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LILA

Liberty Latin America

$18.14

0.14 (0.78%)

05:31
10/17/19
10/17
05:31
10/17/19
05:31
Upgrade
Liberty Latin America rating change  »

Liberty Latin America…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRUS

Cirrus Logic

$54.53

-0.79 (-1.43%)

05:31
10/17/19
10/17
05:31
10/17/19
05:31
Upgrade
Cirrus Logic rating change  »

Cirrus Logic upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 13

    Nov

XHR

Xenia Hotels

05:27
10/17/19
10/17
05:27
10/17/19
05:27
Downgrade
Xenia Hotels rating change  »

Xenia Hotels downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

CYOU

Changyou.com

$9.44

0.12 (1.29%)

, SOHU

Sohu.com

$10.22

-0.16 (-1.54%)

05:26
10/17/19
10/17
05:26
10/17/19
05:26
Hot Stocks
Changyou.com forms independent special committee to review acquisition proposal »

Changyou.com (CYOU)…

CYOU

Changyou.com

$9.44

0.12 (1.29%)

SOHU

Sohu.com

$10.22

-0.16 (-1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRNA

Verona Pharma

$4.07

(0.00%)

05:24
10/17/19
10/17
05:24
10/17/19
05:24
Hot Stocks
Verona completes enrollment in nebulized ensifentrine Phase 2b clinical trial »

Verona Pharma announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIC

Ericsson

$8.63

0.175 (2.07%)

05:22
10/17/19
10/17
05:22
10/17/19
05:22
Earnings
Ericsson reports Q3 EPS (SEK 1.89) vs. SEK 0.83 »

Reports Q3 revenue SEK…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

NFLX

Netflix

05:18
10/17/19
10/17
05:18
10/17/19
05:18
Recommendations
Netflix analyst commentary  »

Piper reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

05:13
10/17/19
10/17
05:13
10/17/19
05:13
Downgrade
Netflix rating change  »

Netflix downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

XOG

Extraction Oil & Gas

$2.50

-0.15 (-5.66%)

05:12
10/17/19
10/17
05:12
10/17/19
05:12
Downgrade
Extraction Oil & Gas rating change  »

Extraction Oil downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

05:10
10/17/19
10/17
05:10
10/17/19
05:10
General news
Maryland Congressman Elijah Cummings has died »

The office of Maryland…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.46

-0.44 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCS

Container Store

$4.54

-0.01 (-0.22%)

05:06
10/17/19
10/17
05:06
10/17/19
05:06
Upgrade
Container Store rating change  »

Container Store upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

EUZOF

Eurazeo

$0.00

(0.00%)

05:03
10/17/19
10/17
05:03
10/17/19
05:03
Recommendations
Eurazeo analyst commentary  »

Eurazeo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.